Sharepoint Solutions
PRODUCTS
-
Titanium dioxide is extensively used in solid dosage forms as an opacifier and colorant. Due to regulatory developments and restrictions by authorities, formulators are increasingly interested in titanium dioxide-free solutions for both dietary supplements and medicinal products. Uniform colored and white coatings applied to tablets not only have an aesthetic function but also improve patient compliance.
-
With all the environmental challenges facing us today, doing everything we can to conserve and preserve our water is imperative. As you know, tens of thousands of leaks go undetected, equating to a staggering 6 billion gallons of water loss daily in the United States. To help combat this water loss, we have developed a program that provides you with the tools and knowledge to help find those undetected leaks. Our program is Leak Detection Pilot Program, and we want to partner with you.
-
Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.
-
The Composable MES for Pharmaceuticals provides a starting point for you to implement a tailored, connected production system with end-to-end traceability and right-the-first-time electronic batch records (eBR).
-
Shorten start-up times for your clinical research studies by eliminating manual spreadsheets once and for all. SuiteSuccess for contract and clinical research organizations (CROs) allows you to unify clinical applications to improve visibility and oversight across the organization in one software platform. Now you can automate inefficient manual processes, from bid to bill, and deliver more quickly and more profitably than your competitors.
WHITE PAPERS AND CASE STUDIES
-
FDA's Regenerative Medicine Advanced Therapy (RMAT) Program
RMAT qualification requires preliminary clinical evidence demonstrating the potential to address an unmet medical need. This designation grants benefits like intensive guidance and faster FDA review.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Real-Time Clinical Data Insights Delivered By Automation And AI
Automated data flows and human‑guided AI enable faster, more reliable oversight into clinical trials. Learn how real‑time insights and unified monitoring support quality, efficiency, and readiness.
-
OEE And Product Inspection
Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Selecting A New Sporicidal Disinfectant: What The Cleanroom Manager Needs To Know
This guide helps cleanroom managers evaluate sporicides by efficacy, safety, and compatibility to ensure contamination control without compromising operational integrity.
-
Delivering Value Across Sites With Unified Quality Operations
Standardizing quality processes across 14 sites has enabled faster lead times. Discover how a unified platform reduces complexity, improves compliance, and delivers greater value for customers.
-
GMP Calibration Management
Learn why generic EAM systems fall short in regulated industries and how purpose-built solutions ensure compliance, efficiency, and audit readiness.
-
Raise The Bar: Setting New Standards For The eCOA Industry
A paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.
-
Challenges And Solutions In Lyophilization Development For ADCs
Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing.
-
Richter BioLogics Drives Efficiency And Compliance With Unified Quality
Learn how one CDMO tripled production, improved audit readiness, and built customer trust by unifying quality systems and embracing a digital-first approach.
-
NuGenesis 9.3 – What's New
Explore the latest features of a user-centric lab management system that comprises data, workflow, and sample management capabilities to support the entire product lifecycle.
NEWS
-
'A More Versatile And Powerful Foundation For Future Photonic Technologies'6/24/2025
The candidate pool for engineered materials that can help enable tomorrow’s cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.
-
Canadian Drinking Water At Risk Long After Wildfires, UBC Study Warns3/4/2026
Canada’s drinking water can remain at risk long after wildfires burn out, according to a UBC-led global review that found water-quality impacts often emerge months or years later—not just immediately after a fire.
-
Huachen AI Parking Management Technology Holding Co., Ltd. Expands Smart City Ecosystem With Launch Of 4G Smart Energy Management And Green Power Arbitrage Initiative2/2/2026
Huachen AI Parking Management Technology Holding Co., Ltd. (NASDAQ: HCAI, “Huachen” or the “Company”), a China-based smart-parking and equipment-structural-parts provider in China, today announced the strategic expansion of its Smart City ecosystem with the launch of its 4G Smart Energy Management and Green Power Arbitrage Initiative.
-
EPA Approves New WIFIA Loans To Strengthen Drinking Water And Wastewater Infrastructure In Oregon And Washington12/18/2025
Today, U.S. Environmental Protection Agency (EPA) is announcing its approval of three Water Infrastructure Finance and Innovation Act (WIFIA) loans totaling $240M.
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.